INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 223 filers reported holding INSMED INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,838,571 | +97.4% | 746,082 | +64.9% | 0.00% | +50.0% |
| Q2 2023 | $9,545,471 | -48.2% | 452,392 | -58.2% | 0.00% | -50.0% |
| Q1 2023 | $18,444,724 | +58.8% | 1,081,802 | +86.1% | 0.00% | +100.0% |
| Q4 2022 | $11,614,234 | +33.2% | 581,293 | +43.6% | 0.00% | 0.0% |
| Q3 2022 | $8,722,000 | +57.1% | 404,915 | +43.8% | 0.00% | +100.0% |
| Q2 2022 | $5,551,000 | +32.6% | 281,500 | +58.1% | 0.00% | 0.0% |
| Q1 2022 | $4,185,000 | +195.6% | 178,088 | +242.6% | 0.00% | – |
| Q4 2021 | $1,416,000 | +88.3% | 51,981 | +90.4% | 0.00% | – |
| Q3 2021 | $752,000 | -96.3% | 27,300 | -96.2% | 0.00% | -100.0% |
| Q2 2021 | $20,499,000 | +121.0% | 720,264 | +164.5% | 0.00% | +100.0% |
| Q1 2021 | $9,274,000 | -76.9% | 272,303 | -77.5% | 0.00% | -80.0% |
| Q4 2020 | $40,201,000 | -40.7% | 1,207,599 | -42.7% | 0.01% | -47.4% |
| Q3 2020 | $67,772,000 | +5.1% | 2,108,674 | -9.9% | 0.02% | -17.4% |
| Q2 2020 | $64,469,000 | +24.5% | 2,340,910 | -27.5% | 0.02% | 0.0% |
| Q1 2020 | $51,786,000 | -19.3% | 3,230,541 | +20.2% | 0.02% | -14.8% |
| Q4 2019 | $64,155,000 | +16.1% | 2,686,575 | -14.2% | 0.03% | +8.0% |
| Q3 2019 | $55,236,000 | -8.7% | 3,131,322 | +32.5% | 0.02% | -7.4% |
| Q2 2019 | $60,506,000 | +74.0% | 2,363,514 | +97.5% | 0.03% | +58.8% |
| Q1 2019 | $34,782,000 | +135.8% | 1,196,458 | +6.4% | 0.02% | +112.5% |
| Q4 2018 | $14,749,000 | +258.2% | 1,124,103 | +452.1% | 0.01% | +700.0% |
| Q3 2018 | $4,117,000 | -35.4% | 203,600 | -24.5% | 0.00% | -66.7% |
| Q2 2018 | $6,376,000 | +1248.0% | 269,588 | +1183.8% | 0.00% | – |
| Q1 2018 | $473,000 | -43.4% | 21,000 | -21.6% | 0.00% | – |
| Q4 2017 | $835,000 | -95.0% | 26,800 | -95.0% | 0.00% | -100.0% |
| Q3 2017 | $16,588,000 | +32.4% | 531,487 | -27.2% | 0.01% | +30.0% |
| Q2 2017 | $12,529,000 | +75.1% | 730,133 | +78.7% | 0.01% | +66.7% |
| Q1 2017 | $7,156,000 | +1171.0% | 408,684 | +860.1% | 0.01% | – |
| Q4 2016 | $563,000 | -94.7% | 42,568 | -94.2% | 0.00% | -100.0% |
| Q3 2016 | $10,720,000 | +157.1% | 738,275 | +74.6% | 0.01% | +120.0% |
| Q2 2016 | $4,169,000 | +5.9% | 422,800 | +94.9% | 0.01% | +25.0% |
| Q4 2015 | $3,938,000 | -82.8% | 216,976 | -82.4% | 0.00% | -81.8% |
| Q3 2015 | $22,950,000 | -37.6% | 1,235,860 | -17.9% | 0.02% | -31.2% |
| Q2 2015 | $36,755,000 | +7.0% | 1,505,122 | -8.9% | 0.03% | -3.0% |
| Q1 2015 | $34,364,000 | +229.0% | 1,652,123 | +144.7% | 0.03% | +230.0% |
| Q4 2014 | $10,446,000 | +921.1% | 675,264 | +761.6% | 0.01% | +900.0% |
| Q3 2014 | $1,023,000 | +125.3% | 78,372 | +245.2% | 0.00% | 0.0% |
| Q2 2014 | $454,000 | -30.8% | 22,705 | -34.1% | 0.00% | 0.0% |
| Q1 2014 | $656,000 | +8100.0% | 34,464 | +4960.8% | 0.00% | – |
| Q2 2013 | $8,000 | – | 681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |